pt141 commercial drug PT-141 (Bremelanotide) - 10MG -
Description
The peptide increases the potential for melanogenesis, and the UV light acts as the trigger to activate it
This research peptide solution is widely used in studies focused on lipid metabolism, energy production, liver function, and metabolic pathways
It is also unlicensed in the UK, and UK regulators have publicly warned about it
Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo
